-
FcRn Inhibitor Market is Predicted to Grow Rapidly During the Study Period (2020–2034) | DelveInsight
16 Apr 2024 17:00 GMT
New York, USA, April 16, 2024 (GLOBE NEWSWIRE) -- FcRn Inhibitor Market is Predicted to Grow Rapidly During the Study Period (2020–2034) | DelveInsight The dynamics of the FcRn inhibitors market are anticipated to change in the coming years due to the …
-
Biocon Biologics gets marketing authorisation for biosimilar from MHRA
14 Nov 2023 11:37 GMT
Representative image
Biotechnology firm Biocon on Monday said its unit has received marketing authorisation for a biosimilar product from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Biocon Biologics has received marketing …
-
Biocon Limited retains eight position amongst Top 10 Employers in global biotech, pharma, biopharma sector
01 Nov 2023 14:11 GMT
… Science magazine.
Employees across Biocon and Biocon Biologics participated in the annual … companies.
Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics, said, “We are … firms and biotech/pharma advertising agencies from the Science Careers …
-
Moderate Psoriasis Market to Accelerate Substantially, Predicts DelveInsight | Key Companies to Watch Out - Soligenix, Biocon, UCB Pharma, AbbVie, Bristol-Myers Squibb, Amgen, Janssen, Pfizer, KoBioLabs
15 Jun 2023 17:00 GMT
New York, USA, June 15, 2023 (GLOBE NEWSWIRE) -- Moderate Psoriasis Market to Accelerate Substantially, Predicts DelveInsight | Key Companies to Watch Out - Soligenix, Biocon, UCB Pharma, AbbVie, Bristol-Myers Squibb, Amgen, Janssen, Pfizer, KoBioLabs The …
-
Cytokine Market Size is projected to reach USD 148.56 billion by 2031, growing at a CAGR of 8.40%: Straits Research
02 Apr 2024 14:40 GMT
New York, United States, April 02, 2024 (GLOBE NEWSWIRE) -- A cytokine is a collection of proteins, peptides, or glycoproteins released by particular cells to regulate the development and function of the immune system and blood cells. By boosting cancer …
-
Basal Cell Carcinoma Market Generated Opportunities, Future Scope 2023-2030 | Biocon, Johnson & Johnson, Abbvie, UCB.
08 May 2023 13:00 GMT
… global industry.
Top Key Players:
Biocon Limited, Johnson & Johnson, Abbvie … to improve products, prices, and advertising.
☛ Clear data-driven insights – Our …
-
LIC, Zee Entertainment, ONGC, Biocon, NDTV, Spicejet, IRCTC, Fortis Healthcare, Adani group stocks in focus
14 Nov 2022 02:56 GMT
… by 2.5% as domestic advertising revenues were lower by 7 … results today: ONGC, Grasim Industries, Biocon, Bharat Forge, Apollo Tyres, IRCTC …
-
Global Insulin Glargine Market Size is projected to reach USD 2200 million by 2031, growing at a CAGR of 6.11%: Straits Research
20 Mar 2024 14:50 GMT
New York, United States, March 20, 2024 (GLOBE NEWSWIRE) -- Insulin glargine is a modified, long-acting form of medical insulin used to treat diabetes types I and II. It is subcutaneously injected. Typically, effects begin one hour following administration …
-
Global Biosimilars Market to Hit Sales of $68.95 Billion by 2028 | Biocon, Sanofi, and Ely Lilly and Company Hold Over 90% of Insulin Biosimilars Market
03 Aug 2022 14:58 GMT
Westford, USA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- According to a study by SkyQuest Technology, biosimilars market generated $12.24 billion in global sales in 2020. This is an 85% increase from the $9.3 billion generated in 2016. This news comes as good news …
-
Biosimilars Market is Projected to Surpass USD 85 billion by 2031, Growing at CAGR 15.5%- Report by Transparency Market Research, Inc.
15 Feb 2024 14:35 GMT
Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global biosimilars market is estimated to flourish at a CAGR of 15.5% from 2022 to 2031. Transparency Market Research projects that the overall …